Navigation Links
BioMed Realty Trust Reports Third Quarter 2007 Financial Results
Date:11/7/2007

November 13, 2007 by calling (888) 286-8010 (domestic) or (617) 801-6888 (international) and using access code 99167797.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty Trust owns or has interests in 68 properties, representing 103 buildings with approximately 8.5 million rentable square feet, as well as approximately 1.9 million square feet of development in progress. These properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at http://www.biomedrealty.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties include, without limitation: general risks affecting the real estate industry (including, without limitation, the inability to enter into or renew leases, dependence on tenants' financial condition, and competition from other developers, owners and operators of real estate); adverse economic or real estate developments in the life science industry or the company's target markets; risks associated with the availability and terms of financing and the use of debt to fund acquisitions and developments; failure to manage effectively the company's growth and expansion into new markets, or to
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. Universal Health Realty Income Trust Announces Dividend
9. Healthcare Realty Trust Announces Public Offering of Common Stock
10. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
11. AUDIO from Medialink and Allergan: Women Not Sure Who to Trust on Anti-Aging Skin Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... ORLEANS, Dec. 6 Sickle cell disease, ... blood cells, is one of the most common ... the world, including more than 70,000 Americans.(1) Research ... the American Society of Hematology highlights intriguing studies ... presents for children with this blood disorder, evaluations ...
(Date:12/6/2009)... Dec. 6, 2009 A new study provides welcome ... as venous thromboembolism (VTE). , The condition is ... year, and occurs when an abnormal clot forms in ... pain and swelling. In some cases, the clot may ... the heart to the lungs, causing a potentially fatal ...
(Date:12/6/2009)... Volunteer organizations and members of the community, in cooperation with the ... create a holiday party. This year,s attendance is expected to soar ... , ... (PRWEB) December 6, 2009 -- ... Greater VA Healthcare System in West Los Angeles, will once again ...
(Date:12/5/2009)... a phase 1/2 clinical trial that it is ... newly diagnosed with multiple myeloma, a cancer of white ... Cancer Institute. , Partial responses or better were seen ... drug combination in the multi-center study, with 74 percent ... phase 2 population, reports Paul G. Richardson, MD, of ...
(Date:12/5/2009)... Cuts for a Cause ,, Why: ... other terminal illnesses affecting children. All proceeds from each hair ... Hospital. Guests will enjoy complimentary beverages and hors d,oeuvres, provided ... Falls Church for all guests. Hoa Lai, a DJ known ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2
... to Reduce Disparities in Meningococcal Vaccination; Increase Educational Efforts ... Dec. 2 The National Foundation for ... Protect.) Meningitis! coalition, composed of many of ... a Call to Action to improve adolescent meningococcal vaccination ...
... safe, research shows , , TUESDAY, Dec. 2 (HealthDay News) -- ... more prone to error than if they were speaking with ... new report finds. , "We think it is basically a ... sitting next to you who is experienced as a driver, ...
... Focus-- , , ... of breakthrough nanoscale platforms for molecular diagnostics, personalized ... of Gary Zweiger, Ph.D., as vice president of ... decade of strategic business development experience with leading ...
... Neuralstem Inc.,(NYSE Alternext US: CUR) announced today that ... University & Hospital of Taiwan, to,advance development of Neuralstem,s ... will focus on Amyotrophic Lateral Sclerosis (ALS,or Lou Gehrig,s ... , (Logo: ...
... Dec. 2 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,Inc. ... CSKI ), a leading,fully integrated pharmaceutical ... China ("PRC"), announced today that Mr. Yu-bo,(Stanley) Hao ... will,also serve on the Company,s Board of Directors. ...
... MYL ) today,announced that it and its subsidiary, ... Novartis Pharmaceuticals Corp., Novartis,Corp. and Novartis International AG related ... Mylan,s Vice Chairman ... to have reached this agreement, which demonstrates our ability ...
Other Medicine News:Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 2Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 3Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 2Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 3Health News:Neuralstem Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials 2Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 2Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 3Health News:Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity 2
(Date:12/4/2009)... Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on ... Reorganization and related amended Disclosure Statement with the United States ... A hearing to consider the adequacy of the Disclosure Statement ... on the confirmation of the Plan scheduled for January 7, ...
(Date:12/4/2009)... (Nasdaq: ONXX ) today announced that it will ... will discuss the data presentations surrounding carfilzomib in relapsed ... American Society of Hematology (ASH) Annual Meeting. ,, The ... on Monday, December 7, 2009. The live webcast ...
(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Record Number of New Medicines in Development for Women 6212 1Record Number of New Medicines in Development for Women 6212 2Gene Therapy Brings New Muscle to Monkeys 61251 1Coffee break 3A Compound brewing new research in colon breast cancer 61247 1Coffee break 3A Compound brewing new research in colon breast cancer 61247 2Coffee break 3A Compound brewing new research in colon breast cancer 61247 3Coffee break 3A Compound brewing new research in colon breast cancer 61247 4Coffee break 3A Compound brewing new research in colon breast cancer 61247 5Coffee break 3A Compound brewing new research in colon breast cancer 61247 6
... 9 Surgeons are testing new,ways of treating ... this country,-- massive bleeding. Investigators from Massachusetts General ... prolong the time surgeons,have to correct bleeding problems ... the surgical researchers found that profound hypothermia,effectively treated ...
... 9 In an effort to increase,access and ... The Leukemia & Lymphoma Society and Cleveland Clinic ... Clinical,Trial Center for Hematologic Malignancies. This innovativecollaboration ... trials available to patients in their community so ...
Other Medicine Technology:Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 2Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 3Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 4Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 5The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals 2The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals 3The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals 4
... is recommended for separations of DNA fragments ... that are easy to handle, and remains ... minimizes the risk of cracking or breaking. ... (GQT) products with similar sieving properties, is ...
... Agarose-HR™ High Resolution - ... from 50 to 1000 ... for sizing PCR fragments, ... by restriction enzyme digestion, ...
The reading of agglutinations process in Diana Reader is by image treatment which allows great sensitivity....
... designed for medium to ... centers and reference laboratories ... antibody screening. It will ... functions including blood group ...
Medicine Products: